Back
Stoke Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
58
STOK
Stoke Therapeutics, Inc.
Last Price:
$36.73
Seasonality Move:
15.92%
7 Day Trial
ALL ACCESS PASS
$
7
Stoke Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Stoke Therapeutics, Inc. has on average historically risen by 57.4% based on the past 6 years of stock performance.
-
Stoke Therapeutics, Inc. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Stoke Therapeutics, Inc. Stock Undervalued?The current Stoke Therapeutics, Inc. [STOK] share price is $36.41. The Score for STOK is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
STOK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Stoke Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Stoke Therapeutics, Inc. has on average historically risen by 57.4% based on the past 6 years of stock performance.
Stoke Therapeutics, Inc. Stock Rating
Buy
58
Stoke Therapeutics, Inc. (STOK)
is a Buy
Is Stoke Therapeutics, Inc. overpriced?
-
Stoke Therapeutics, Inc. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Stoke Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
stoketherapeutics.com
52-Week Data
52-Week High:
38.69
52-Week Low:
5.35
Prediction Charts
Market Cap:
2.1B
Price in USD:
36.41
Volume:
653.6K
Beta:
0.92
Technical Analysis
SMA50:
32.04
SMA100:
30.96
SMA200:
23.09
52-Wk Change:
355.69%
Stock Predictions
-
Is Stoke Therapeutics, Inc. stock public?Yes, Stoke Therapeutics, Inc. is a publicly traded company.
-
What is the Stoke Therapeutics, Inc. stock quote today?The Stoke Therapeutics, Inc. stock price is 36.41 USD today.
-
How to buy Stoke Therapeutics, Inc. stock online?You can buy Stoke Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-9 | 31.77 | 31.99 | 32.38 | 30.75 |
| Feb-10 | 30.90 | 32.44 | 32.95 | 30.79 |
| Feb-11 | 32.49 | 32.22 | 32.90 | 30.91 |
| Feb-12 | 32.95 | 31.89 | 33.28 | 31.47 |
| Feb-13 | 32.35 | 31.91 | 33.24 | 31.58 |
| Feb-17 | 31.84 | 31.09 | 32.27 | 30.50 |
| Feb-18 | 30.84 | 30.98 | 31.72 | 30.83 |
| Feb-19 | 31.38 | 34.37 | 34.67 | 30.68 |
| Feb-20 | 34.26 | 34.29 | 35.39 | 33.60 |
| Feb-23 | 34.94 | 36.23 | 37.73 | 34.31 |
| Feb-24 | 36.50 | 35.50 | 37.05 | 35.30 |
| Feb-25 | 35.68 | 35.50 | 37.11 | 35.23 |
| Feb-26 | 35.02 | 35.55 | 36.08 | 34.17 |
| Feb-27 | 35.20 | 36.41 | 36.61 | 34.66 |
Stoke Therapeutics, Inc. Earnings
Stoke Therapeutics, Inc. Earnings Report: Per Share Stoke Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Stoke Therapeutics, Inc. Forecast Revenue Growth
Stoke Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Stoke Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.25 per share, and an increase next year of $0.42 per share.
* Stoke Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.